thiazolyl blue has been researched along with pentoxifylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isbrucker, R; Peterson, TC; Slysz, G | 1 |
| Chen, M; Nadler, JL; Wu, R; Yang, Z | 1 |
2 other study(ies) available for thiazolyl blue and pentoxifylline
| Article | Year |
|---|---|
The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antimetabolites; Bucladesine; Cell Division; Cells, Cultured; Cholagogues and Choleretics; Cyclic AMP; Dideoxyadenosine; Drug Interactions; Enzyme Inhibitors; Fibroblasts; Humans; Pentoxifylline; Platelet-Derived Growth Factor; Stimulation, Chemical; Taurochenodeoxycholic Acid; Tetrazolium Salts; Thiazoles; Ursodeoxycholic Acid | 1998 |
Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Cytokines; DNA Damage; Fluorescent Dyes; In Situ Nick-End Labeling; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Membranes; Mitochondria; Pentoxifylline; Rats; Stimulation, Chemical; Tetrazolium Salts; Thiazoles | 2002 |